Galectin Therapeutics Inc.GALTNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-41.77M
↓ 89% vs avg
Percentile
P0
Near historical low
Streak
6 yr
Consecutive declineContracting
Average
$-22.10M
Historical baseline
PeriodValueYoY Change
2024$-41.77M-26.7%
2023$-32.97M-6.1%
2022$-31.06M-27.8%
2021$-24.31M-18.0%
2020$-20.60M-89.9%
2019$-10.85M-6.6%
2018$-10.18M+35.9%
2017$-15.89M+3.2%
2016$-16.41M+3.4%
2015$-16.98M-